Trials / Completed
CompletedNCT04799977
COVID-19: Post-covid Olfactory Disorders Assessment
Persistent Olfactory Loss After COVID-19 : Olfactive Disorder, Psychiatric and/or Cognitive Assessments With and Without a Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Covid 19 cause an olfactory loss in more than 80% of cases. This loss most often regresses but leaves 20% of patients with an olfactory complaint, particularly with regard to the quality of daily life. The neuro-cognitive implications involved with COVID19 and the consequences of persistent olfactory loss remain unknown. The effectiveness of therapeutic management, in particular olfactory re-education, has not yet been clarified. Objectives are the assessment of patients olfactory disorders, psychiatrics and neurocognitives specificities after a COVID, before and after treatment or specific cares.
Conditions
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2021-03-16
- Last updated
- 2025-04-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04799977. Inclusion in this directory is not an endorsement.